The Role of Non-Coding RNAs in Glioma

Author(s)

Goenka, Anshika ; Tiek, Deanna Marie ; Song, Xiao ; Iglesia, Rebeca Piatniczka ; Lu, Minghui ; Hu, Bo ; Cheng, Shi-Yuan

• Document type: Journal article
• Source: BIOMEDICINES; v. 10, n. 8, p. 24-pg., 2022-08-01.

Abstract

For decades, research in cancer biology has been focused on the protein-coding fraction of the human genome. However, with the discovery of non-coding RNAs (ncRNAs), it has become known that these entities not only function in numerous fundamental life processes such as growth, differentiation, and development, but also play critical roles in a wide spectrum of human diseases, including cancer. Dysregulated ncRNA expression is found to affect cancer initiation, progression, and therapy resistance, through transcriptional, post-transcriptional, or epigenetic processes in the cell. In this review, we focus on the recent development and advances in ncRNA biology that are pertinent to their role in glioma tumorigenesis and therapy response. Gliomas are common, and are the most aggressive type of primary tumors, which account for similar to 30% of central nervous system (CNS) tumors. Of these, glioblastoma (GBM), which are grade IV tumors, are the most lethal brain tumors. Only 5% of GBM patients survive beyond five years upon diagnosis. Hence, a deeper understanding of the cellular non-coding transcriptome might help identify biomarkers and therapeutic agents for a better treatment of glioma. Here, we delve into the functional roles of microRNA (miRNA), long non-coding RNA (lncRNA), and circular RNA (circRNA) in glioma tumorigenesis, discuss the function of their extracellular counterparts, and highlight their potential as biomarkers and therapeutic agents in glioma. (AU)

• FAPESP's process: 20/03714-8 - Cellular prion protein in glioblastoma stem cells biology: its role in the acquisition of temozolomide resistance
• Grantee: Rebeca Piatniczka Iglesia
• Support Opportunities: Scholarships abroad - Research Internship - Post-doctor